Boutique CRO Focus Sannova Analytical is a specialized bioanalytical and analytical CMC CRO with a 15+ year track record and a state-of-the-art 21,000 square foot lab, indicating strong capabilities for complex, novel, and generic therapeutics that can be positioned to mid to large pharma/Biotech companies seeking high-touch, end-to-end services.

Expansion Signals Recent leadership changes and a private equity-backed investment in 2022 suggest strategic growth and potential capacity expansion or service line enhancements, creating opportunity for new collaborations, expanded testing menus, and longer-term partnerships.

Revenue Scale With reported revenue in the 10–25 million range and a focused niche in bioanalytical and CMC testing, Sannova presents as a mid-market partner for pharma/biotech segments seeking personalized CRO services without the scale of the largest players.

Strategic Fit Operating as a fast, on-time, end-to-end services provider for complex programs aligns well with companies looking to de-risk development timelines, meet regulatory milestones, or supplement larger CROs during peak workloads.

Partnership Potential Historical executive leadership hires and prior CEO transition indicate openness to strategic partnerships and advisory relationships, suggesting avenues for co-development support, feasibility studies, and joint service offerings to expand client access and win rates.